UK cell therapy start-up agrees AstraZeneca partnership worth up to $2bn

Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news